VEOZAH (fezolinetant)
MENOPAUSAL SYMPTOMS SUPPRESSANT - NEUROKININ RECEPTOR ANTAGO · VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Astellas Pharma US
Drug class
Menopausal Symptoms Suppressant - Neurokinin Receptor Antago
The therapeutic class "Menopausal Symptoms Suppressant - Neurokinin Receptor Antagonist" comprises nonhormonal medications formulated to manage moderate to severe vasomotor symptoms, such as hot flashes and night sweats, associated with menopause. Read more about Menopausal Symptoms Suppressant - Neurokinin Receptor Antago
2 drugs in this class 2 manufacturers
Drugs in Menopausal Symptoms Suppressant - Neurokinin Receptor Antago
LYNKUET (elinzanetant)
MENOPAUSAL SYMPTOMS SUPPRESSANT - NEUROKININ RECEPTOR ANTAGO · VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE
Bayer HealthCare
Filter & compare in the drug finder →
Opens the drug finder with Menopausal Symptoms Suppressant - Neurokinin Receptor Antago preselected. Add indication or manufacturer filters there.
The therapeutic class "Menopausal Symptoms Suppressant - Neurokinin Receptor Antagonist" comprises nonhormonal medications formulated to manage moderate to severe vasomotor symptoms, such as hot flashes and night sweats, associated with menopause.
Agents in this class—most notably neurokinin 3 (NK3) or dual neurokinin 1 and 3 (NK1/3) receptor antagonists like fezolinetant and elinzanetant—work by competitively blocking neurokinin B signaling on kisspeptin/neurokinin B/dynorphin neurons within the hypothalamus.
By mitigating this receptor signaling, these drugs restore equilibrium to the hypothalamic thermoregulatory center disrupted by estrogen withdrawal.
Consequently, this class provides a targeted endocrine alternative for postmenopausal individuals experiencing disruptive vasomotor symptoms, particularly those with contraindications or preferences against hormone replacement therapy.
-
connectrx.com
The therapeutic class "Menopausal Symptoms Suppressant - Neurokinin Receptor Antagonist" comprises nonhormonal medications formulated to manage moderate to severe vasomotor symptoms, such as hot flashes and night sweats, associated with menopause Agents in this class—most notably neurokinin 3 (NK3) or dual neurokinin 1 and 3 (NK1/3) receptor antagonists like fezolinetant and elinzanetant—work by competitively blocking neurokinin B signaling on kisspeptin/neurokinin B/dynorphin neurons within the...
-
contemporaryobgyn.net
The therapeutic class "Menopausal Symptoms Suppressant - Neurokinin Receptor Antagonist" comprises nonhormonal medications formulated to manage moderate to severe vasomotor symptoms, such as hot flashes and night sweats, associated with menopause By mitigating this receptor signaling, these drugs restore equilibrium to the hypothalamic thermoregulatory center disrupted by estrogen withdrawal Consequently, this class provides a targeted endocrine alternative for postmenopausal individuals experie...
-
connectrx.com
Agents in this class—most notably neurokinin 3 (NK3) or dual neurokinin 1 and 3 (NK1/3) receptor antagonists like fezolinetant and elinzanetant—work by competitively blocking neurokinin B signaling on kisspeptin/neurokinin B/dynorphin neurons within the hypothalamus
-
straighthealthcare.com
Agents in this class—most notably neurokinin 3 (NK3) or dual neurokinin 1 and 3 (NK1/3) receptor antagonists like fezolinetant and elinzanetant—work by competitively blocking neurokinin B signaling on kisspeptin/neurokinin B/dynorphin neurons within the hypothalamus By mitigating this receptor signaling, these drugs restore equilibrium to the hypothalamic thermoregulatory center disrupted by estrogen withdrawal
-
gayawellness.com
Consequently, this class provides a targeted endocrine alternative for postmenopausal individuals experiencing disruptive vasomotor symptoms, particularly those with contraindications or preferences against hormone replacement therapy
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.